Johnson & Johnson (JNJ) Tops Q3 EPS by 3c; Boosts FY11 Outlook
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $275.23 -1.15%
EPS Growth %: +3.6%
Financial Fact:
Provision for taxes on income (Note 5): 1.01B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +3.6%
Financial Fact:
Provision for taxes on income (Note 5): 1.01B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q3 EPS of $1.24, $0.03 better than the analyst estimate of $1.21. Revenue for the quarter came in at $16 billion versus the consensus estimate of $16.02 billion.
Johnson & Johnson sees FY2011 EPS of $4.95-$5.00, versus the consensus of $4.96. The company had previously guided to $4.90-$5.
Johnson & Johnson sees FY2011 EPS of $4.95-$5.00, versus the consensus of $4.96. The company had previously guided to $4.90-$5.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
- UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
